Medicine and Dentistry
Drug Therapy
100%
Systematic Review
100%
Attention Deficit Disorder
100%
Comorbidity
100%
Adolescence
100%
Randomized Controlled Trial
50%
Placebo
30%
Meta-Analysis
20%
Effect Size
20%
Atomoxetine
20%
Guanfacine
20%
Disease
10%
Cohort Analysis
10%
Adverse Event
10%
Pervasive Developmental Disorder
10%
Tic Disorder
10%
Major Depressive Episode
10%
Generalized Anxiety Disorder
10%
Narrative
10%
Methylphenidate
10%
Oppositional Defiant Disorder
10%
Mental Disorder
10%
Amphetamine Derivative
10%
Rating Scale
10%
Keyphrases
Comorbidity
100%
Attention Deficit Hyperactivity Disorder
100%
Randomized Controlled Trial
40%
Placebo-controlled
30%
Systematic Literature Review
20%
Atomoxetine
20%
Guanfacine Extended-release
20%
Autism Spectrum Disorder
10%
Clinical Analysis
10%
Adverse Events
10%
Major Depressive Disorder
10%
Rating Scales
10%
Meta-analysis
10%
Comorbid
10%
Meta-analysis of Randomized Controlled Trials
10%
Caregivers
10%
Treatment Efficacy
10%
Efficacy Outcomes
10%
Limited Information
10%
Embase
10%
Evidence-based
10%
Disorders Diagnosis
10%
MEDLINE
10%
Children with Attention Deficit
10%
Psychiatric Comorbidity
10%
Amphetamine
10%
Tic Disorders
10%
Lowest Effective Dose
10%
Comorbid Conditions
10%
Low Quality Data
10%
Methylphenidate
10%
Tourette Syndrome
10%
Oppositional Defiant Disorder
10%
Treatment Safety
10%
Drug Selection
10%
Narrative Synthesis
10%
Generalized Anxiety Disorder
10%
Substantial Burden
10%
Pharmacology, Toxicology and Pharmaceutical Science
Attention Deficit Disorder
100%
Comorbidity
100%
Randomized Controlled Trial
50%
Placebo
30%
Atomoxetine
20%
Guanfacine
20%
Disease
10%
Adverse Event
10%
Autism
10%
Cohort Study
10%
Amphetamine Derivative
10%
Generalized Anxiety Disorder
10%
Oppositional Defiant Disorder
10%
Methylphenidate
10%
Tic
10%
Major Depression
10%
Immunology and Microbiology
Adolescence
100%
Comorbidity
100%
Embase
12%